Literature DB >> 2681204

Determination of the secondary structure of interleukin-8 by nuclear magnetic resonance spectroscopy.

G M Clore1, E Appella, M Yamada, K Matsushima, A M Gronenborn.   

Abstract

The solution conformation of interleukin-8 (IL-8), a small protein of 72 residues with a wide range of proinflammatory activities, has been investigated by two-dimensional NMR spectroscopy. The 1H-NMR spectrum of IL-8 is assigned in a sequential manner and regular elements of secondary structure are identified on the basis of a qualitative interpretation of the nuclear Overhauser, coupling constant and amide exchange data. The IL-8 monomer contains a triple stranded anti-parallel beta-sheet arranged in a Greek key and a long C-terminal helix (residues 57-72). It is shown that IL-8 is a dimer in solution in which the interface is principally formed by six backbone hydrogen bonds between residues 25, 27, and 29 of one monomer and residues 29, 27, and 25, respectively, of the other. As a result, the two units of the dimer form a contiguous six-stranded anti-parallel beta-sheet. The secondary structure of IL-8 is similar to that found in the crystal structure of the sequence related protein platelet factor 4.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681204

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The human cytokine I-309 is a monocyte chemoattractant.

Authors:  M D Miller; M S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Interactions of interleukin-8 with the human chemokine receptor CXCR1 in phospholipid bilayers by NMR spectroscopy.

Authors:  Sang Ho Park; Fabio Casagrande; Leah Cho; Lauren Albrecht; Stanley J Opella
Journal:  J Mol Biol       Date:  2011-10-12       Impact factor: 5.469

3.  Crystal structure of interleukin 8: symbiosis of NMR and crystallography.

Authors:  E T Baldwin; I T Weber; R St Charles; J C Xuan; E Appella; M Yamada; K Matsushima; B F Edwards; G M Clore; A M Gronenborn
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

4.  A simple method to quantitatively measure polypeptide JHNH alpha coupling constants from TOCSY or NOESY spectra.

Authors:  Y Wang; A M Nip; D S Wishart
Journal:  J Biomol NMR       Date:  1997-12       Impact factor: 2.835

5.  Distinct Differences in Structural States of Conserved Histidines in Two Related Proteins: NMR Studies of the Chemokines CXCL1 and CXCL8 in the Free Form and Macromolecular Complexes.

Authors:  Krishna Mohan Sepuru; Krishna Rajarathnam
Journal:  Biochemistry       Date:  2018-10-02       Impact factor: 3.162

6.  Identification of amino acids involved in the binding of hMIP-1 alpha to CC-CKR1, a MIP-1 alpha receptor found on neutrophils.

Authors:  J M Crisman; P J Elder; N M Wilkie; P E Kolattukudy
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

7.  Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium.

Authors:  D Schwartz; A Andalibi; L Chaverri-Almada; J A Berliner; T Kirchgessner; Z T Fang; P Tekamp-Olson; A J Lusis; C Gallegos; A M Fogelman
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Biological activity of the growth factor-induced cytokine N51: structure-function analysis using N51/Interleukin-8 chimeric molecules.

Authors:  J N Heinrich; E C O'Rourke; L Chen; H Gray; K S Dorfman; R Bravo
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

9.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Authors:  L M Webb; M U Ehrengruber; I Clark-Lewis; M Baggiolini; A Rot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  The 9E3 protein: immunolocalization in vivo and evidence for multiple forms in culture.

Authors:  M Martins-Green; A Aotaki-Keen; L M Hjelmeland; M J Bissell
Journal:  J Cell Sci       Date:  1992-03       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.